古汉医药
(000590)
| 流通市值：24.99亿 | | | 总市值：25.00亿 |
| 流通股本：2.39亿 | | | 总股本：2.39亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 71,667,915.65 | 337,673,206.5 | 224,815,751.88 | 142,437,429.61 |
| 营业收入 | 71,667,915.65 | 337,673,206.5 | 224,815,751.88 | 142,437,429.61 |
| 二、营业总成本 | 79,589,898.46 | 365,095,549.48 | 250,688,000.98 | 170,030,690.76 |
| 营业成本 | 40,985,792.67 | 186,561,222.18 | 119,899,263.37 | 78,434,251.57 |
| 税金及附加 | 1,933,281.96 | 7,714,533.01 | 5,424,786.08 | 3,375,405.44 |
| 销售费用 | 12,710,224.5 | 62,056,134.46 | 45,418,416.26 | 33,870,611.95 |
| 管理费用 | 19,919,829.53 | 92,029,633.68 | 66,053,068.67 | 44,446,076.64 |
| 研发费用 | 3,630,302.85 | 13,914,662.03 | 11,663,083.02 | 8,292,249.34 |
| 财务费用 | 410,466.95 | 2,819,364.12 | 2,229,383.58 | 1,612,095.82 |
| 其中:利息费用 | 491,086.36 | 3,388,277.13 | 2,654,622.75 | 1,907,967.66 |
| 其中:利息收入 | 109,801.04 | 635,080.24 | 476,514.79 | 339,545.26 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | - | 778,142.82 | 92,339.12 | 36,284.33 |
| 资产处置收益 | -241,452.27 | 2,422,610.35 | 3,537,636.01 | 3,444,349.77 |
| 资产减值损失(新) | 360,663.19 | -26,795,401.95 | -46,466.87 | -640.48 |
| 信用减值损失(新) | -2,733.61 | -6,001,161.91 | 6,554,200.25 | 6,537,613.08 |
| 其他收益 | 1,122,488.15 | 5,840,806.16 | 3,347,722.56 | 2,519,531.35 |
| 四、营业利润 | -6,683,017.35 | -51,177,347.51 | -12,386,818.03 | -15,056,123.1 |
| 加:营业外收入 | 4,835.01 | 3,686,115.2 | 1,224,354.97 | 200,501.22 |
| 减:营业外支出 | 816.12 | 2,098,102.72 | 1,573,697.11 | 109,602.54 |
| 五、利润总额 | -6,678,998.46 | -49,589,335.03 | -12,736,160.17 | -14,965,224.42 |
| 减:所得税费用 | 128,937.2 | 485,218.81 | 2,326,785.66 | 2,298,316.8 |
| 六、净利润 | -6,807,935.66 | -50,074,553.84 | -15,062,945.83 | -17,263,541.22 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -6,807,935.66 | -50,074,553.84 | -15,062,945.83 | -17,263,541.22 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -6,813,530.68 | -50,516,758.93 | -14,820,604.47 | -17,170,056.39 |
| 少数股东损益 | 5,595.02 | 442,205.09 | -242,341.36 | -93,484.83 |
| 扣除非经常损益后的净利润 | -7,527,314.84 | -62,139,878.26 | -20,681,828.54 | -22,652,173.34 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.03 | -0.21 | -0.06 | -0.07 |
| (二)稀释每股收益 | -0.03 | -0.21 | -0.06 | -0.07 |
| 九、综合收益总额 | -6,807,935.66 | -50,074,553.84 | -15,062,945.83 | -17,263,541.22 |
| 归属于母公司股东的综合收益总额 | -6,813,530.68 | -50,516,758.93 | -14,820,604.47 | -17,170,056.39 |
| 归属于少数股东的综合收益总额 | 5,595.02 | 442,205.09 | -242,341.36 | -93,484.83 |
| 公告日期 | 2026-04-28 | 2026-03-31 | 2025-10-30 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |